Navigation Links
The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R)
Date:2/10/2009

CHICAGO, Feb. 10 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Alternext: FHC), which manufactures and markets the FC and FC2 Female Condoms(R), today reported its operating results for the first quarter of FY2009.

While unit sales increased during the three months ended December 31, 2008, the Company's net revenues decreased 7% to approximately $5.3 million, compared with approximately $5.7 million in the first quarter of the previous fiscal year. The decline in revenues reflects a continuing shift in product shipments towards the Company's FC2 Female Condom(R), which is priced lower and generates a higher gross profit margin than FC1. In addition, unit sales have been temporarily limited by a significant increase in orders for FC1, our first generation product, by customers requiring final FDA approval to order FC2. At times, the increased demand has exceeded our capacity to produce FC1. We elected not to invest in expanding FC1 production capacity in anticipation of securing FC2 FDA approval, discontinuing FC1 and investment in expanding FC2 production capacity. Given final FDA approval, it is anticipated that these customers will purchase FC2, eliminating this temporary limitation.

The Company's net income attributable to common shareholders increased 98% to $1,608,816, or $0.06 per diluted share, during the first quarter of FY2009, compared with net income attributable to common shareholders of $813,968, or $0.03 per share, in the corresponding period of the previous fiscal year. The Company was positively impacted by the strengthening of the U.S. dollar relative to the British pound sterling in the first quarter of FY2009, resulting in a foreign currency gain of $1,194,107, compared with a currency gain of $115,358 in the first quarter of FY2008.

Gross profit increased 3% to $2,441,194 in the most recent quarter, compared with $2,366,116 in the first quarter of FY2008.
'/>"/>

SOURCE The Female Health Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Female Hormones Deter Salt-Sensitive Hypertension
2. The Female Health Company Schedules First Quarter Conference Call for February 10, 2009
3. Living with females extends the reproductive life of the male mouse, says Penn veterinary researcher
4. FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable
5. Surprising Results on Smoking Research Hispanic Versus White Female Smokers
6. Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom
7. The Female Health Company Schedules Year End FY2008 Conference Call for December 1, 2008
8. Surprisingly, female models have negative effect on men
9. Large-Scale Survey Reveals Low Sexual Desire Most Common Distressing Female Sexual Problem, Affecting Up to One in 10 Women
10. Sexual Trauma Haunts Many Female Vets
11. The Health Insurance Advocate Radio Show Expands to Springfield, Missouri, and Reaches a New All-Time Ratings High for Female Listenership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... life. The last stage, when two daughter cells split ... of cell biology in the Victorian era. For just ... this final step, when the dividing cell creates a ... to this process by those early biologists, cytokinesis, translates ... highly active and organized series of events. Scientists have ...
(Date:10/31/2014)... (PRCHN) at Case Western Reserve University School of ... million in federal grants awarded to improve community ... Disease Control and Prevention (CDC) renewed the PRCHN,s ... funds will support the center,s ongoing efforts in ... interventions that prevent and reduce chronic disease in ...
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review ... fat loss program ever developed. It promises to provide users ... is no wonder after all that this has become the ... nutrition and workout fat loss program was created by Joel ... to the author of this fat loss system, the method ...
(Date:10/31/2014)... At the start of 2014, numerous ... carbon monoxide poisoning in their homes. Now, as 2015 ... family-owned, Missouri-based heating and cooling company is taking a ... start the home heating season with the assurance that ... Beginning Nov. 1, 2014, E and Q Heating and ...
(Date:10/31/2014)... 2014 Energy Textiles has recently added ... gear is now available online, and Energy Textile is ... Celliant infrared-active athletic gear over compression gear. , ... has been signed for Under Armour to provide team ... eight years. In light of this decision, Energy Textiles ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4
... care enhancement program for patients with multiple chronic ... patient/family communications and their knowledge of their patients, ... at the Johns Hopkins Bloomberg School of Public ... of Annals of Family Medicine , found ...
... NY JULY 20, 2010 TCT 2010 (Transcatheter ... technologies and practices in interventional cardiology that will directly ... (September 21-25 in Washington, DC), late breaking data from ... cardiology techniques, and the interactions and effectiveness of new ...
... during and after pregnancy were able to cut the incidence ... study published in the British Journal of Dermatology ... at the Norwegian University of Science and Technology (NTNU), compared ... to women who were given a placebo. Use of the ...
... Reinberg HealthDay Reporter , MONDAY, July 19 (HealthDay ... of developing persistent ringing in the ear -- a condition ... one U.S. ear specialist called the data used for the ... a connection between cell phone use and tinnitus. The ...
... , MONDAY, July 19 (HealthDay News) -- People in an Alabama ... in their bodies were much more likely to have high blood ... PCBs actually caused their hypertension. If a direct connection does ... exposed to PCBs, which were once used in many products but ...
... in HIV/AIDS (BC-CfE) published an important study today in ... reinforces the view that the benefits of highly active ... to significantly preventing the transmission and spread of HIV. ... HIV, HAART uses a combination of drugs to stop ...
Cached Medicine News:Health News:Guided Care improves physician satisfaction with patient/family communications 2Health News:TCT 2010 to have significant impact on interventional cardiology practices and patient care 2Health News:Probiotics use in mothers limits eczema in their babies 2Health News:Can Cell Phones Cause Another Kind of Ringing? 2Health News:Could PCBs Help Boost Blood Pressure? 2Health News:Could PCBs Help Boost Blood Pressure? 3Health News:HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study 2Health News:HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study 3
(Date:10/31/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ... on the development of oral drug delivery systems, ... call to discuss the clinical results from its ... proprietary oral insulin capsules, to treat type 1 ... a.m. Eastern time. Shareholders and other ...
(Date:10/31/2014)... , October 31, 2014 ... Inc. (NASDAQ: NSPH ), Isis Pharmaceuticals Inc. ... HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... 30, 2014, the NASDAQ Composite ended at 4,566.14, up ...
(Date:10/31/2014)... British Journal of Urology ... discuss "male orgasmic dysfunction" with their doctor prior to ... symptoms while preserving sexual function     ... a paper in the British Journal of Urology International ... discuss with their doctors the likely impact of treatment ...
Breaking Medicine Technology:Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2
... Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or ... September 30, 2009. All figures included herein were prepared ... Mexican pesos. Also, the following consolidated figures show the Company,s ... , 3Q09 Highlights (vs. 3Q08) , During ...
... 26 ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer ... announced that it will release financial results for the third ... Monday, November 2, 2009. The Company will host a ... 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss ...
Cached Medicine Technology:Genomma Lab Internacional Announces Third Quarter 2009 Results 2Genomma Lab Internacional Announces Third Quarter 2009 Results 3ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call 2
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a ... microplate format. It is designed for the ... thyroglobulin (TG) in serum or plasma. The ... 1: Calibrators, controls and patient samples are ...
Medicine Products: